DUBLIN--(BUSINESS WIRE)--The "Global Fertility Testing Devices Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global fertility testing devices market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Fertility testing devices are electronic devices that are used to monitor and analyze the changes in hormone levels in urine, body temperature, saliva, and other samples to predict or detect the fertility of the user.
The decreasing fertility rate in females and the availability of such devices and kits on online websites and portal is the major driving factor for the market. The growing technological advancements, rise in prevalence of obesity, and the rising median age of first-time pregnancies in women are also the factors that are driving the market growth during the forecast period. Additionally, the adoption of the point of care devices and the increasing prevalence of ovarian diseases are the key attributing factor for fueling the growth of the fertility testing devices market.
Furthermore, increasing acceptance of basal body temperature-based ovulation monitors, and the rising acceptance rate of fertility devices are the factors that are propelling the growth of the market. Additionally, the increasing use of mobile applications and websites for ovulation tracking is the major restraining factor for the market.
Besides, the cost of ovulation monitoring devices is high, and the Lack of predictive power to confirm ovulation is further hampering the growth of the market. However, pharma healthcare firms are investing in the manufacturing of fertility testing devices that will turn out to be a significant opportunity to the market.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
- Abbott Laboratories, Inc.
- Alfa Scientific Designs, Inc.
- Ava Science Inc.
- Babystart Ltd.
- bioMerieux S.A
- bioZhena Corp.
- Church & Dwight Co, Inc.
- Cook Medical Inc.
- Eli Lilly And Co.
- Fairhaven Health, LLC
- Fertility Focus Ltd.
- Gemc Technology Group Ltd.
- Geratherm Medical AG
- GlaxoSmithKline plc
- Hilin Life Products, Inc.
- Janssen Global Services, LLC
- Merck KGaA
- Novartis International AG
- Pfizer Inc.
- SPD Swiss Precision Diagnostics GmbH
- TaiDoc Technology Corp
For more information about this report visit https://www.researchandmarkets.com/r/3qiriq
